Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

EMAP II Activators

EMAP II Activators represent a class of chemicals that can indirectly influence the activity of the EMAP II protein by modulating associated cellular processes, particularly inflammation and apoptosis.Endothelial monocyte-activating polypeptide II (EMAP II) is a proinflammatory cytokine that is known to play a role in immune response regulation and has been implicated in the process of angiogenesis and immune cell recruitment. EMAP II activators are chemical agents that can either directly or indirectly enhance the biological activity of EMAP II, thus influencing the processes in which this cytokine is involved.

Direct activators of EMAP II interact with the protein at a molecular level, potentially by binding to specific sites on the molecule to induce a conformational change that could increase its biological activity, promote its interaction with receptors on the surface of target cells, or prevent its degradation. Such activators mimic natural ligands or enhance the affinity of EMAP II for its receptors, thus amplifying the downstream signaling cascades initiated by this cytokine. Indirect activators of EMAP II, on the other hand, work by increasing the expression levels of the EMAP II gene, thereby raising the concentration of the cytokine in the tissue or the systemic circulation. This can occur through the modulation of transcription factors or through epigenetic alterations that make the EMAP II gene more accessible for transcription. Other indirect mechanisms include the stabilization of EMAP II mRNA, leading to greater translation and protein synthesis, or the inhibition of proteases responsible for EMAP II degradation, which would prolong the half-life of the cytokine.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates Protein Kinase C (PKC), which can induce inflammation and apoptosis, potentially leading to increased EMAP II expression.

Lipopolysaccharide, E. coli O55:B5

93572-42-0sc-221855
sc-221855A
sc-221855B
sc-221855C
10 mg
25 mg
100 mg
500 mg
$98.00
$171.00
$425.00
$1560.00
12
(2)

LPS can induce inflammation and upregulate EMAP II expression.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine is a broad-spectrum protein kinase inhibitor that can induce apoptosis, potentially leading to increased EMAP II expression.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin induces endoplasmic reticulum stress and can stimulate apoptosis, potentially increasing EMAP II expression.

Hydrogen Peroxide

7722-84-1sc-203336
sc-203336A
sc-203336B
100 ml
500 ml
3.8 L
$31.00
$61.00
$95.00
28
(1)

H2O2 induces oxidative stress that can lead to inflammation and apoptosis, potentially increasing EMAP II expression.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

Dexamethasone is a glucocorticoid that can influence inflammation, and might potentially modulate EMAP II expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor that can modify AKT signaling, potentially influencing EMAP II expression during apoptosis.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

Cyclosporin A inhibits calcineurin, potentially influencing EMAP II expression during inflammation and apoptosis.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin is an mTOR inhibitor that can modify cell proliferation and survival, potentially influencing EMAP II expression.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a PI3K inhibitor that can modify AKT signaling, potentially influencing EMAP II expression during apoptosis.